Literature DB >> 11730928

The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection.

S Suradhat1, M Intrakamhaeng, S Damrongwatanapokin.   

Abstract

The level of antigen-specific interferon-gamma (IFN-gamma) production can be used as an indicator of cellular immunity. In this study, we investigated the role of cellular immune response in protection against classical swine fever virus (CSFV). Pigs were vaccinated once with CSFV vaccine and challenged 6 days post-vaccination (dpv). Vaccinated animals had significantly higher CSFV-specific IFN-gamma secreting cells than the unvaccinated pigs (p<0.05) at the time of challenge and were protected against CSFV infection, whereas the control pigs died within 14 days post-infection (dpi). In the second experiment, pigs were vaccinated once with either CSFV vaccine or CSFV vaccine combined with Aujeszky's disease (AD) vaccine and challenged at 140 dpv. All vaccinated pigs developed both CSFV-specific, cellular and antibody responses and were protected against CSFV infection. However, differences in cellular, but not antibody, responses were observed in the two vaccinated groups. The group vaccinated with CSFV vaccine developed a significantly higher number of CSFV-specific, IFN-gamma secreting cells (p<0.05), exhibited a shorter fever period and less pathological changes, when compared with the group vaccinated with the combined vaccine. The kinetics of IFN-gamma production, following challenge in the two vaccinated groups, were also different. Taken together, our results indicated that CSFV-specific, IFN-gamma production could be detected early after antigen exposure and correlated with protection against CSFV challenge. Our findings highlight the role of cellular immune responses in porcine anti-viral immunity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730928     DOI: 10.1016/s0165-2427(01)00389-0

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  17 in total

1.  Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.

Authors:  Yimin Wang; Jin Yuan; Xin Cong; Hua-Yang Qin; Chun-Hua Wang; Yongfeng Li; Su Li; Yuzi Luo; Yuan Sun; Hua-Ji Qiu
Journal:  Clin Vaccine Immunol       Date:  2015-08-26

2.  RNA Seq analysis for transcriptome profiling in response to classical swine fever vaccination in indigenous and crossbred pigs.

Authors:  Shalu Kumari Pathak; Amit Kumar; G Bhuwana; Vaishali Sah; Vikramadiya Upmanyu; A K Tiwari; A P Sahoo; A R Sahoo; Sajjad A Wani; Manjit Panigrahi; N R Sahoo; Ravi Kumar
Journal:  Funct Integr Genomics       Date:  2017-03-30       Impact factor: 3.410

3.  Limited protection conferred by a DNA vaccine against a lethal pseudorabies virus infection at day 5 postvaccination.

Authors:  Daniel Dory; Anne-Marie Torché; Véronique Béven; Roland Cariolet; André Jestin
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

4.  Assessment of the phenotype and functionality of porcine CD8 T cell responses following vaccination with live attenuated classical swine fever virus (CSFV) and virulent CSFV challenge.

Authors:  Giulia Franzoni; Nitin V Kurkure; Daniel S Edgar; Helen E Everett; Wilhelm Gerner; Kikki B Bodman-Smith; Helen R Crooke; Simon P Graham
Journal:  Clin Vaccine Immunol       Date:  2013-08-21

5.  Porcine circovirus type 2 (PCV2) infection decreases the efficacy of an attenuated classical swine fever virus (CSFV) vaccine.

Authors:  Yu-Liang Huang; Victor Fei Pang; Chun-Ming Lin; Yi-Chieh Tsai; Mi-Yuan Chia; Ming-Chung Deng; Chia-Yi Chang; Chian-Ren Jeng
Journal:  Vet Res       Date:  2011-12-01       Impact factor: 3.683

6.  Challenge of pigs with classical swine fever viruses after C-strain vaccination reveals remarkably rapid protection and insights into early immunity.

Authors:  Simon P Graham; Helen E Everett; Felicity J Haines; Helen L Johns; Olubukola A Sosan; Francisco J Salguero; Derek J Clifford; Falko Steinbach; Trevor W Drew; Helen R Crooke
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

7.  Early protection events in swine immunized with an experimental live attenuated classical swine fever marker vaccine, FlagT4G.

Authors:  Lauren G Holinka; Vivian O'Donnell; Guillermo R Risatti; Paul Azzinaro; Jonathan Arzt; Carolina Stenfeldt; Lauro Velazquez-Salinas; Jolene Carlson; Douglas P Gladue; Manuel V Borca
Journal:  PLoS One       Date:  2017-05-24       Impact factor: 3.240

8.  CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses.

Authors:  Patricia Renson; Mireille Le Dimna; André Keranflech; Roland Cariolet; Frank Koenen; Marie-Frédérique Le Potier
Journal:  Vet Res       Date:  2013-02-11       Impact factor: 3.683

Review 9.  Immune Responses Against Classical Swine Fever Virus: Between Ignorance and Lunacy.

Authors:  Artur Summerfield; Nicolas Ruggli
Journal:  Front Vet Sci       Date:  2015-05-07

10.  Monoclonal and oligoclonal TCR AV and BV gene usage in CD4+ T cells from pigs immunised with C-strain CSFV vaccine.

Authors:  Chunyan Wang; Shoujie Li; Huaijie Jia; Guohua Chen; Yongxiang Fang; Shuang Zeng; Xiaobing He; Wenjuan Yao; Qiwang Jin; Wenyu Cheng; Yuan Feng; Hong Yin; Zhizhong Jing
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.